VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SPRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SPRYARS Pharmaceuticals, Inc.
$3.89$386M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSPRYQuarterly Cash Flow

ARS Pharmaceuticals, Inc. (SPRY) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ARS Pharmaceuticals, Inc. (SPRY) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

SPRY Cash Flow Statement

Quarterly statement

SPRY Cash Flow Statement

ARS Pharmaceuticals, Inc. (SPRY) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-33.71M-60.93M-44.95M-43.48M-47.05M-39.59M-40.74M42M-14.47M-7.28M-6.71M-17.41M-12.76M-16.67M-12.43M-20.5M-5.68M-6.97M-6.92M-21.3M
Operating CF Margin %-89.4%-181.02%-198.17%-154.82%-144.76%-251.91%-511%48.51%-699.56%-1455.8%----166690%-62145%--3006.35%-1503.02%-1044.49%-2825.6%
Operating CF Growth %28.34%-53.89%-10.32%-203.53%-225.2%-443.92%-507.18%341.33%-13.35%56.33%46.01%15.09%-124.62%-139.02%-79.48%3.79%70.28%50.66%43.24%-
Net Income-35.59M-62.34M-60.62M-41.32M-51.15M-44.88M-33.94M49.93M-19.13M-12.52M-10.29M-7.17M-14.87M-17.37M-14.96M-14.43M-6.58M-6.42M-7.25M-23.46M
Depreciation & Amortization415K416K397K417K2.35M279K280K158K21K18K11K12K21K20K-1.79M14K7K488K50K430K
Stock-Based Compensation8.12M12.39M7.42M5.74M5.69M5.37M5.3M4.26M3.59M3.37M3.31M2.28M2.61M02.25M4.76M460K0264K0
Deferred Taxes00000000000-11.18M00000000
Other Non-Cash Items-6.66M1.44M-745K-852K-2.87M693K-1.96M-1.67M2.51M-1.9M-1.98M9.43M-1.56M346K0-10.06M710K-86K-1K5.15M
Working Capital Changes0-12.84M8.6M-7.46M-1.07M-1.05M-10.42M-10.68M-1.46M3.76M2.24M-10.77M1.03M335K2.07M-781K-276K-956K12K-3.43M
Change in Receivables-5.89M-20.63M-839K11.18M-14.01M-13.25M-1.13M-7.4M-773K000000328K-328K000
Change in Inventory-2.28M13K-294K-9.72M963K-4.78M-8.45M-5.76M-183K00000000000
Change in Payables1.23M10.52M10.31M-9.06M10.96M12.81M4.17M12.02M03.07M1.34M-8.88M1.12M224K000-267K0-388K
Cash from Investing23.41M41.57M27.79M24.11M-44.98M48.57M29.06M-101.76M16.82M-12.65M-8.51M26.04M-46.64M44.97M-111.55M-126K-30K-22K-21K-25.68M
Capital Expenditures0000-197K-51K-91K-302K-140K-38K-83K91K-43K-30K-193K-126K-30K-22K-21K-550K
CapEx % of Revenue----0.61%0.32%1.14%0.35%6.77%7.6%---300%965%-15.87%4.74%3.17%72.94%
Acquisitions00000000000-25.95M46.6M0000000
Investments--------------------
Other Investing000-2M-5.86M00-5M-2.5M0025.95M-46.6M0000000
Cash from Financing27.76M3.2M159K1.13M100.05M2.7M725K70.92M680K545K258K1.8M921K2.85M1.32M193.82M-1.56M-623K-908K275K
Debt Issued (Net)000-732K96.99M0000000000-5.95M-909K-910K-908K0
Equity Issued (Net)0786K62K1.78M479K2.7M725K1.53M680K545K258K1.8M921K2.85M000287K0275K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing27.76M2.41M97K83K2.58M0069.38M0000001.32M199.77M-647K000
Net Change in Cash17.46M-16.16M-17M-18.24M8.02M11.68M-10.95M11.16M3.03M-19.38M-14.96M10.44M-58.48M31.16M-122.66M173.2M-7.27M-15.3M-7.85M-46.62M
Free Cash Flow-33.71M-60.93M-44.95M-43.48M-47.24M-39.64M-40.83M41.7M-14.61M-7.32M-6.79M-17.31M-12.81M-16.7M-12.62M-20.62M-5.71M-7M-6.95M-21.86M
FCF Margin %-89.4%-181.02%-198.17%-154.82%-145.36%-252.23%-512.14%48.17%-706.33%-1463.4%----166990%-63110%--3022.22%-1507.76%-1047.66%-2898.54%
FCF Growth %28.64%-53.69%-10.07%-204.28%-223.43%-441.79%-501.1%340.86%-14.06%56.18%46.18%16.05%-124.19%-138.69%-81.72%5.64%70.26%52.84%43.23%-
FCF per Share-0.34-0.61-0.45-0.44-0.48-0.40-0.420.43-0.15-0.08-0.07-0.18-0.13-0.18-0.13-0.22-0.06-0.07-0.07-0.62
FCF Conversion (FCF/Net Income)0.95x0.98x0.74x1.05x0.92x0.88x1.20x0.84x0.76x0.58x0.65x2.43x0.86x0.96x0.83x1.42x0.86x1.09x0.96x4.14x
Interest Paid02.33M0000000000000366K00114K0
Taxes Paid00000000000000000000